Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
17.54
0.00 (-0.03%)
Apr 25, 2025, 1:28 PM EDT - Market open

Apellis Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
2,2013,9697,0935,7184,6034,332
Upgrade
Market Cap Growth
-44.04%-44.04%24.06%24.22%6.25%121.45%
Upgrade
Enterprise Value
2,2554,0366,7375,1234,3853,977
Upgrade
Last Close Price
17.5431.9159.8651.7147.2857.20
Upgrade
PS Ratio
2.785.0817.8975.8169.1517.28
Upgrade
PB Ratio
9.5517.3736.4733.6623.1721.18
Upgrade
P/TBV Ratio
9.6317.3736.4733.6623.1721.18
Upgrade
EV/Sales Ratio
2.895.1716.9967.9265.8715.87
Upgrade
Debt / Equity Ratio
2.062.060.570.661.061.85
Upgrade
Asset Turnover
0.930.930.510.090.070.37
Upgrade
Inventory Turnover
3.633.633.156.35--
Upgrade
Quick Ratio
3.713.712.343.565.937.03
Upgrade
Current Ratio
4.254.253.104.296.257.15
Upgrade
Return on Equity (ROE)
-93.55%-93.55%-290.14%-353.93%-370.20%-288.86%
Upgrade
Return on Assets (ROA)
-12.32%-12.32%-41.73%-45.27%-36.39%-19.79%
Upgrade
Return on Capital (ROIC)
-20.54%-20.54%-109.93%-107.49%-67.63%-34.54%
Upgrade
Earnings Yield
-8.99%-4.98%-7.45%-11.41%-16.21%-7.96%
Upgrade
FCF Yield
-4.01%-2.22%-8.39%-9.01%-12.26%-3.83%
Upgrade
Buyback Yield / Dilution
-4.40%-4.40%-11.84%-25.70%-12.32%-20.79%
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q